18.10.2011:
Given today’s pharmaceutical markets, it is difficult to develop new drugs for diseases that primarily affect people in developing countries. Supplementary business models are needed to address this. Experience with developing drugs for rare diseases gives some insight into promising incentive...
18.10.2011:
Essential medicines are those that satisfy the priority health care needs of the population. Access to essential medicines is a human right. Why do these medicines have a price that makes them unattainable for a large share of the world's population? Not all medicines are equally important. The...